Samsung biologics made that deal only from the data, that was even before CytoDyn completed their successful covid19 trial. Now with the successful trial the billions of dollars will start rolling in.
NASDAQ hasn't sent CYDY anything. Did you look up what I posted about the other day? If NASDAQ sent anything, CYDY would have posted a PR and filed the 8k. Good or bad.
Standard operating procedure. It's a material event if they were to be told they didn't qualify, since it would potentially affect the stock price.
Do you have inside information or a link or other proof that FDA will not approve leronlimab? Your predictions will be proven wrong.
News 
Market Data 
Discover 
